FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

NCT06201065 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Lenvatinib
DRUG: Toripalimab
DRUG: oxaliplatin , fluorouracil, and leucovorin

Sponsor

Sun Yat-sen University